BioStem Technologies, Inc. (BSEM) Tops Q3 EPS by 6c

BioStem Technologies, Inc. (OTC: BSEM) reported Q3 EPS of $0.42, $0.06 better than the analyst estimate of $0.36. Revenue for the quarter came in at $82.56 million versus the consensus estimate of $78.22 million.

For earnings history and earnings-related data on BioStem Technologies, Inc. (BSEM) click here.

You May Also Be Interested In

• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M
• Macquarie favors BSL, RWC, REH in Australian earnings season